PRISM Biotech
New York, N.Y., February 29, 2024 - PRISM MarketView - Enveric Biosciences (NASDAQ: ENVB), a biotechnology company focused on developing neuroplastogenic small-molecule therapeutics for mental health conditions announced the signing of three non-binding term sheets with ...

29 February 2024

PRISM View
New York, N.Y., February 29, 2024 - PRISM MarketView - LivePerson, Inc. (LPSN) needs some resuscitation as it drags the PRISM NextGen Tech & AI Index today as its largest detractor, down ~42%. The company announced Q4 earnings reporting a quarterly loss of $0.18 per ...

29 February 2024

PRISM View
New York, N.Y., February 29, 2024 - PRISM MarketView - Polestar Automotive Holding UK PLC (Nasdaq: PSNY) has announced securing $950 million through a three-year loan facility provided by a syndicate of 12 international banks, including notable names like BNP Paribas and...

29 February 2024

PRISM Biotech
New York, N.Y., February 29, 2024 - PRISM MarketView - Leading cannabinoid and psychedelic medicine biotechnology company, Incannex Healthcare (Nasdaq: IXHL), has achieved  positive topline results in its Phase 2 clinical trial of psilocybin in generalized anxiety disord...

29 February 2024

News
NEW YORK, N.Y., February 29, 2024 - PRISM MarketView, a leading provider of unbiased market insight and company news, recognizes the remarkable contributions of companies developing treatments for the 10,000 rare diseases affecting more than 30 million Americans.

29 February 2024

PRISM View
New York, N.Y., February 28, 2024 - PRISM MarketView - PRISM Zombie Index Leader Beyond Meat, Inc. (BYND), is seeing a big gain today as its trading close to 45% higher on its recent earnings release. However, outside of exceeding the Street’s Q4 revenue estimates ($73.7...

28 February 2024

PRISM Biotech
New York, N.Y., February 28, 2024 - PRISM MarketView - Mind Medicine (MindMed) Inc. (Nasdaq: MNMD) has announced its financial results for the year ended December 31, 2023, closing out a “highly productive” year with positive Phase 2b results for MM120 in the treatment o...

28 February 2024

PRISM Biotech
New York, N.Y., February 28, 2024 - PRISM MarketView - Rare disease company, Capricor Therapeutics (Nasdaq: CAPR), has been granted an in-person Type-B meeting with the FDA to discuss chemistry, manufacturing and controls (CMC) plans for commercial launch for the potenti...

28 February 2024

PRISM Biotech
New York, N.Y., February 27, 2024 - PRISM MarketView - Voyager Therapeutics (Nasdaq: VYGR) has selected a lead development candidate in its Friedreich’s Ataxia (FA) program. The company expects the program to advance into first-in-human clinical trials in 2025. Selection...

27 February 2024

PRISM View
New York, N.Y., February 27, 2024 - PRISM MarketView - Digital advertising tech company PubMatic, Inc. (PUBM) has rose ~27% after announcing record earnings after the market closed on Monday. The stock is currently trading around $21/share with 1.7M shares being traded c...

27 February 2024

47
48
49
50
51
52
53
We use cookies to run our website, analyze your use of our services, manage your online preference & personalize ad content. By accepting our cookies, you’ll get relevant content and social media features, personalized ads, and an enhanced browsing experience. To manage your choices, click „Cookie Settings”. Necessary cookies are required for the core website functionality and cannot be rejected. For more information, see our Cookie Policy.
Cookie settings
Cookies used on the site are categorized and below you can read about each category and allow or deny some or all of them, except for Necessary Cookies which are required to provide core website functionality. When categories that have been previously allowed are disabled, all cookies assigned to that category will be removed from your browser. You can see a list of cookies assigned to each category and detailed information on those cookies in the “Cookie Policy” tab.
Necessary cookies
Some cookies are required to provide core functionality. The website won't function properly without these cookies and they are enabled by default and cannot be disabled.
Preferences
Preference cookies enables the website to remember information to customize how the website looks or behaves for each user. This may include storing selected currency region, language or color theme.
Analytical cookies
Analytical cookies help us improve our website by collecting and reporting information on its usage.
Marketing cookies
Marketing cookies are used to track visitors across websites to allow publishers to display relevant and engaging advertisements. By enabling marketing cookies, you grant permission for personalized advertising across various platforms.